Trident Ltd has announced the departure of CFO Avneesh Barua, effective from May 29, 2026, due to personal matters. The firm is in the process of appointing a new CFO, with further details on the successor yet to be disclosed.

Elin Electronics experienced a significant decline in Q4 earnings, with the EBITDA falling by 70% year-over-year to ₹60 million. The shrinking margins dropped to 1.8%, marking a substantial decrease from the previous year's 6.4%.

Cipla Limited executed a block deal worth approximately INR 35.7 crore on the NSE, selling around 251,702 shares at INR 1,417 apiece.

The NSE BSE Healthcare Index monitors the performance of various healthcare-related businesses, such as pharmaceuticals and hospitals. Companies like Wockhardt are among those being tracked in this index. This provides a comprehensive overview of market trends within the healthcare sector. [economictimes.com]

Harrisons Malayalam announces a pre-tax profit of INR 29.2 crore for FY26, despite an issue with junior staff's alleged fund misuse, which has since been addressed through corrective measures.

DMCC Specialty Chemicals reported a significant Q4 FY26 revenue of INR 177 crores, boosted by increased raw material prices. However, the Middle East crisis caused disruptions in sulfur supply, affecting the Roha plant's operations and resulting in higher working capital requirements.

Kotak Securities has advised investors to consider decreasing their holdings in Hindalco due to a revised price target of ₹1,100. The company's Q4 EBITDA surpassed expectations, with anticipated coal cost benefits expected from FY28. However, potential risks are still present and should be considered before making investment decisions.

Tata Steel executed a significant block trade on the National Stock Exchange, amounting to approximately 4.7 million shares worth INR 99.8 crore at around INR 210.2 each.

Citi continues to advise against investing in Ramco Cements due to a revised target price of ₹775, a significant decrease from the previous ₹1025. Investors may want to reconsider their holdings.

Paramount Communications saw a decrease in Q4 EBITDA, with earnings dropping to ₹300 million compared to ₹317 million in the same period last year. The margin also contracted, dipping to 5.2% from 6.3%.

Team India Guaranty will announce their financial results for the fiscal year 2026 on May 29, 2026. A trading window for designated individuals has been closed from April 1, 2026, and will reopen only 48 hours after the results are declared.

Sun Pharma has released their Q4 financial results, with specifics available now on ET NOW. Investors are encouraged to stay updated for further analysis of these earnings.

Alphageo India's board meeting on May 27th will assess Q4 and full-year 2026 financial results, including potential dividends, with the trading window remaining shut till the outcomes are announced.

Eurotex Industries reported a loss for Q4 FY26, despite an unfavorable audit opinion and cash drain. The company is currently embroiled in a court case regarding a 30.54 million rupee electricity duty dispute, impacting its overall financial standing.

Today, Sun Pharma, Hindalco, Eicher Motors, Torrent Pharma, and NTPC Green are set to release their Q4 results, with ITC, LIC, GAIL, Emami, Max Health, JSW Cement, Va Tech, and 3M India also under the spotlight for their financial performances. Investors will closely monitor these companies' results to gauge their performance in the recent quarter.

Honasa Consumer's Q4 EBITDA more than doubled year-over-year, reaching ₹771M, and the company's profit margins also saw a substantial increase to 11.8%.

Godrej Properties and Tata Projects have sealed a ₹1,100 crore deal to collaborate on various projects in Gurgaon. This partnership signifies a significant move in the real estate sector for both companies.

Following impressive Q4 performance, Life Insurance Corporation (LIC) could witness a potential 37% growth. Brokerages remain optimistic about its future and recommend buying the shares.

GAIL's Q4 net profit experienced a decline, falling to ₹12.6 billion from ₹16 billion quarter-on-quarter, despite an uptick in revenue which climbed to ₹347.9 billion compared to ₹340.7 billion in the previous quarter.

KIMS Hospitals reported a 35.3% year-on-year increase in Q4 revenue to ₹1,084 crore, with a 19.9% EBITDA margin. Despite this growth, profit after tax (PAT) decreased due to expansion costs. The new units played a significant role in the overall FY26 revenue growth of 28.2%.

Allcargo Terminals has taken over full ownership of Speedy Multimodes by purchasing a 15% stake through a share swap agreement, aiming to strengthen its logistics operations.

Credo Brands reported a 6% year-on-year growth in Q4 revenue at INR 162.3 crores, while the full-year revenue slightly decreased by 4%. The EBITDA for Q4 was INR 41.6 crores, marking a 14% increase from the previous year and focusing on MUFTI 2.0 strategy.

Adani Total Gas has announced the appointment of Sanjay Pandita as its new CEO, starting from May 22. The change in leadership marks a new era for the company.

Quick Heal Tech reports a significantly larger net loss of ₹199 million in Q4 compared to last year, with a corresponding decline in quarterly revenue by 25%, reaching ₹487 million.

Netweb and E2E experienced gains of up to 4.5% in their shares due to Nvidia's strong Q1 earnings. Notably, Netweb secured an AI server contract worth Rs 1,734 crores, while E2E is supporting India's AI mission with the help of NVIDIA.

Grasim surpasses expectations in Q4, driven by impressive VSF performance, signaling continued growth potential. Mankind Pharma exhibits strong domestic expansion, while Jubilant Food faces margin challenges. Apollo Hospitals receives mixed reviews due to valuation concerns, but a positive outlook following AB Capital's equity raise.

Despite a significant 25% year-on-year increase in Q4 net profit, Xpro India's total revenue dropped by 16% YoY to approximately ₹1.34 billion due to a decrease in quarterly sales.

Carysil's Q4 profits have surged by 46%, demonstrating an impressive year-on-year growth and enhanced profitability. Shareholders can expect a dividend payment of ₹3 per share for the final dividend this quarter.

Bosch Limited has scheduled its Q4 FY26 investor call, where they will present their findings. The automotive sector is experiencing growth, primarily due to increased demand in rural areas, resulting in a 10-20% increase in volumes for the fiscal year 2026.

Morgan Stanley maintains its bullish stance on PI Industries, setting a target price of INR 3,883. Investors may find this stock appealing due to the firm's optimistic outlook.

IOL Chemicals incurred a fine of INR 2,000 for a minor oversight in their BSE filing regarding the shareholding pattern, which was submitted one day late. Despite this, they successfully adhered to NSE's timeline, and the delay on BSE was due to an initial misunderstanding of rules.

Ask Automotive saw a 24.2% increase in Q4 profit to ₹72 crore, with revenue surging by 35.3% to ₹1,154 crore. The company's FY26 PAT grew by 21.2%, thanks to new facilities and a solar plant that boosted operational efficiency.

Karnataka Bank has announced a final dividend of ₹5 per share, marking a positive move towards returning value to its shareholders.

Zydus Lifesciences reported robust Q4 earnings, primarily fueled by a thriving US division. Jefferies maintains its 'Buy' recommendation and a price target of ₹1,200, attributing continued strength to their India operations.

IOL Chemicals & Pharmaceuticals has received an unmodified opinion from auditors for their financial results in the fiscal year 2026. The board has approved the establishment of a new Triacetin plant with a capacity of 6,000 MTPA and an expansion of Pantoprazole production capacity from 240 to 276 MTPA, both funded internally without external financing.

Pharmaceutical companies IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma, Wockhardt, Lupin, Divi's, Zydus, Torrent, JB Chem, Glenmark, and Ajanta have surged to their highest levels in the past year. Other notable gains were seen among stocks like these.

AvenuesAI will review its full-year 2026 financial results at a board meeting on May 29. This includes Q4 numbers. Insider trading is temporarily suspended from April 1 to June 2, as per regulations.

Mankind Pharma reports a 12% increase in Q4 revenue to 34.43 billion INR, with EBITDA surging 36%. Domestic sales, particularly chronic therapies, contributed to a healthy 27% EBITDA margin. International growth remains modest.

BPCL is currently grappling with temporary difficulties stemming from under-recovery costs associated with retail fuel sales, putting pressure on their earnings.

Elara has adjusted its recommendation for Amber Enterprises, now recommending a 'Buy', while lowering the target price to INR 8,630 due to a revised market outlook. The previous target was INR 9,625.